ME
McIlrath & Eck’s Novo Nordisk NVO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.8K | Hold |
200
| – | – | ﹤0.01% | 547 |
|
2025
Q1 | $13.9K | Hold |
200
| – | – | ﹤0.01% | 549 |
|
2024
Q4 | $17.2K | Hold |
200
| – | – | ﹤0.01% | 509 |
|
2024
Q3 | $23.8K | Hold |
200
| – | – | ﹤0.01% | 442 |
|
2024
Q2 | $28.5K | Sell |
200
-505
| -72% | -$72.1K | ﹤0.01% | 372 |
|
2024
Q1 | $90.5K | Buy |
+705
| New | +$90.5K | 0.01% | 190 |
|
2023
Q2 | – | Sell |
-13
| Closed | -$2.07K | – | 926 |
|
2023
Q1 | $2.07K | Buy |
+13
| New | +$2.07K | ﹤0.01% | 773 |
|
2021
Q3 | – | Sell |
-337
| Closed | -$28K | – | 819 |
|
2021
Q2 | $28K | Hold |
337
| – | – | 0.01% | 329 |
|
2021
Q1 | $23K | Hold |
337
| – | – | 0.01% | 319 |
|
2020
Q4 | $24K | Hold |
337
| – | – | 0.01% | 274 |
|
2020
Q3 | $23K | Hold |
337
| – | – | 0.01% | 241 |
|
2020
Q2 | $22K | Hold |
337
| – | – | 0.01% | 225 |
|
2020
Q1 | $20K | Hold |
337
| – | – | 0.01% | 189 |
|
2019
Q4 | $20K | Hold |
337
| – | – | 0.01% | 240 |
|
2019
Q3 | $17K | Hold |
337
| – | – | 0.01% | 246 |
|
2019
Q2 | $18K | Hold |
337
| – | – | 0.01% | 215 |
|
2019
Q1 | $18K | Buy |
+337
| New | +$18K | 0.01% | 215 |
|
2018
Q3 | – | Sell |
-801
| Closed | -$37K | – | 563 |
|
2018
Q2 | $37K | Hold |
801
| – | – | 0.02% | 135 |
|
2018
Q1 | $39K | Buy |
801
+1
| +0.1% | +$49 | 0.02% | 139 |
|
2017
Q4 | $43K | Buy |
+800
| New | +$43K | 0.03% | 139 |
|